This paper aims to study the efficacy of aspirin combined with prednisone in the treatment of recurrent spontaneous abortion. This research officially started in March 2021 and ended in March 2022. 72 patients with recurrent spontaneous abortion admitted to our hospital during this research period were selected as the observation objects. They were divided into two groups according to the order of admission: a control group and an experimental group. The control group received routine treatment, and the experimental group received aspirin combined with prednisone treatment. The observation indicators and pregnancy outcomes of the two groups of patients were compared before and after treatment. There was no significant difference in coagulation function, IL-4, hormones, endometrial receptivity, and immune function indicators between the two groups of patients before treatment (P>0.05). After treatment, the research indicators of both groups of patients were effectively improved, but the improvement degree of the experimental group was significantly better than that of the control group, and the pregnancy outcome of the experimental group was better (P<0.05). Conclusion: Aspirin combined with prednisone treatment can achieve ideal efficacy in patients with recurrent spontaneous abortion, and is worthy of clinical promotion.

Lingyan Zhang. Study on the Efficacy of Aspirin Combined with Prednisone in the Treatment of Recurrent Spontaneous Abortion. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 11: 17-22. https://doi.org/10.25236/IJFM.2023.051103.

[1] Omda E, A. F, Fattah E A, et al. Combined Low Dose Aspirin and Steroids vs Aspirin Only in Management of Unexplained Recurrent Miscarriage [J]. The Egyptian Journal of Hospital Medicine, 2019, 75(5).

[2] Hongxia Liu. The effect of low-molecular-weight heparin combined with aspirin on the maternal and fetal outcomes and thrombotic test indicators of recurrent miscarriage caused by PTS [J]. Journal of Aerospace Medicine, 2022, 33 (3): 274-276

[3] Huicai Zhang, Yinxia Cheng, Jing Wang. The clinical application value of low molecular weight heparin sodium combined with aspirin in the treatment of recurrent miscarriage [J]. Journal of Mathematical Medicine and Pharmacy, 2022, 35 (2): 272-275

[4] Jingjing Zong, Heyue Li, Minghui You, et al The effect of Gushen Antai Pill combined with prednisone and aspirin in the treatment of recurrent miscarriage and its effect on the imbalance of helper T cell 17/regulatory T cell [J]. Chinese Sexual Science, 2022, 31 (8): 57-61

[5] Chunling Wang. Analysis of the efficacy of low-dose aspirin combined with low molecular weight heparin calcium, progesterone, and dexamethasone in the treatment of recurrent miscarriage with hyperhomocysteinemia [J]. Modern Drug Applications in China, 2021, 15 (19): 23-25

[6] Samira E, Asma K, Akram V, et al. The hormone-sensitive lipase C-60G polymorphism is correlated with recurrent spontaneous abortion in women with polycystic ovary syndrome [J]. Gene Reports, 2023, 32.

[7] G P. [Preliminary recommendations for the use of progestins and progesterone. A first for a health agency: Is the precautionary principle going to replace evidence-based medicine?][J]. Gynecologie, obstetrique, fertilite & senologie, 2023, 51(10).

[8] Mingzhu Ao, Haihua Yu. The effect of aspirin combined with prednisone in the treatment of recurrent miscarriage and its impact on patient immune balance and pregnancy outcome [J]. Chinese Journal of Family Planning, 2023, 31 (3): 575-580

[9] Yumei Liu, Chunqing Hu, Xiaoyong Tang, et al The effect of aspirin combined with glucocorticoids on recurrent miscarriage and its impact on vWF, PAI-1, and coagulation related indicators in pregnant women [J]. Chinese and Foreign Medical Research, 2021, 19 (4): 13-16

[10] Yang Shi, Wanzeng Ma, Yanhong Feng, et al Gushen Antai pill assisted with prednisone and aspirin in the treatment of unexplained recurrent miscarriage and its effects on peripheral blood immune cells, FDP, and D-D [J]. Chinese Journal of Family Planning, 2022, 30 (8): 1734-1739

[11] Hong Li, Xia Guo. The clinical efficacy of aspirin combined with low molecular weight heparin in the treatment of recurrent miscarriage complicated with antiphospholipid syndrome [J]. Clinical Medical Research and Practice, 2021, 6 (27): 138-139,155.

[12] Yinhua Liang. The efficacy of aspirin combined with low-molecular-weight heparin as an adjuvant therapy for unexplained recurrent miscarriage and its effects on estradiol γ- The impact of interferon [J]. Journal of Mathematical Medicine and Pharmacy, 2022, 35 (5): 738-740

[13] Linling Mo, Dan Peng, Jinling Song, etc. Study on the efficacy and immunomodulatory effect of low molecular weight heparin and low-dose aspirin in the treatment of recurrent abortion with pre thrombotic state [J]. Chinese Sexual Science, 2022, 31 (9): 81-85

[14] Liangyan Zhou. The effect of low-molecular-weight heparin combined with aspirin treatment on the expression level of D-dimer fibrin degradation products and pregnancy outcomes in patients with recurrent miscarriage [J]. China Maternal and Child Health, 2021, 36 (17): 4016-4019

[15] Xiaosun Li, The effect of low-molecular-weight heparin combined with aspirin on the survival rate, hemorheology, and pregnancy outcome in patients with recurrent miscarriage [J]. Journal of Shanxi Health Vocational College, 2022, 32 (2): 8-9

[16] Ruifan Wang, Na Yang, Xiaoxia Fan. The efficacy of aspirin combined with dexamethasone in the treatment of habitual abortion patients and its impact on coagulation and immune function [J]. Chinese and Foreign Women’s Health Research, 2022 (5): 43-44, 94

[17] Bae J, Jung Y, Lee J, et al. EP20.05: Future risk of metabolic syndrome after recurrent spontaneous abortion: a cohort study using UK Biobank [J]. Ultrasound in Obstetrics & Gynecology, 2023, 62.

[18] Yanping Lei, Caijuan Li. The efficacy of aspirin combined with dexamethasone in the treatment of habitual abortion patients and its impact on coagulation and immune function [J]. Thrombosis and Hemostasis, 2021, 27 (5): 825-827